Svenja is a pharmaceutical biotechnology scientist interested in tumor immunology and genetics. With a diverse scientific background including molecular biology, microbiology and virology, she recently worked in the field of single cell sequencing and is now motivated to study the role of genetic variation in modulating anti-tumor immunity during her PhD.